Sat. May 25th, 2024

VMocion, a technology company specializing in virtual reality (VR) and other extended reality (XR) experiences, has secured $3 million in seed funding. The company’s proprietary technology aims to reduce motion sickness in XR environments by stimulating the inner ear’s vestibular system. VMocion’s technology provides users with a sense of physical motion while in XR, eliminating motion sickness by sending electrical impulses to the inner ear via wearable contact points placed on the skin. The impulses stimulate the ear’s vestibular system, creating a sense of balance and spatial orientation. The company plans to use the funding to advance its technology.

Another company, OVR Technology, is also working to make XR feel more realistic. OVR offers ION, a wearable scent technology that allows users to experience the smell of the virtual environment.

Key points:

  • VMocion secures $3 million in seed funding for its virtual motion technology.
  • The company’s technology aims to reduce motion sickness in XR environments by stimulating the inner ear’s vestibular system.

VMocion’s technology provides users with a sense of physical motion while in XR and eliminates motion sickness by sending electrical impulses to the inner ear via wearable contact points placed on the skin. The technology stimulates the ear’s vestibular system, creating a sense of balance and spatial orientation. The company plans to use the funding to advance its technology.

Another company, OVR Technology, is working on making XR more realistic by offering wearable scent technology that allows users to experience the smells of the virtual environment.

Related Post